» Articles » PMID: 28991772

Prevalence of Depression, Anxiety and Insomnia in Chronic Kidney Disease Patients and Their Co-Relation with the Demographic Variables

Overview
Specialty General Medicine
Date 2017 Oct 10
PMID 28991772
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic kidney disease (CKD) is an emerging health problem in both developed and developing countries. Depression, anxiety and sleep disturbances are highly prevalent in patients with chronic disease, but remain undertreated despite significant negative consequences on patients' health. Assessment of key components of mental health early in disease course will help to identify high risk subjects in whom modifying these predictors will help in providing active and healthy life in CKD patients.

Methods: We did a cross sectional study in 200 patients of CKD stage III to V-D fulfilling the eligibility criteria who were on follow up in a single tertiary care center in the state of Haryana, India. We assessed the prevalence of anxiety, depression and insomnia and their correlation with demographic variables in these patients. The structured questionnaire used in this study gathered information on respondent demographic and disease characteristics, and information obtained from the HADS and PSQI questionnaire. Factors associated with anxiety, depression and insomnia were examined by a multiple logistic regression analysis.

Results: The prevalence of anxiety, depression and insomnia were found to be 71%, 69% and 86.5% respectively. As the CKD stage advanced, the prevalence as well as severity of these parameters increased. Anxiety, depression and sleep quality were found to be significantly correlated to unemployment, low income, low education, urban residence and presence of co-morbidities. The anxiety, depression and insomnia scores were found to have a strong negative correlation with eGFR, hemoglobin, serum calcium (p <0.01) and a positive correlation with TLC, blood urea, serum creatinine and serum phosphate (p <0.05).

Conclusion: We observed a high prevalence of anxiety, depression and insomnia in CKD patients. There is a need to develop strategies to accurately identify "high risk" subjects who may benefit from preventive measures before complications occur. By identifying CKD patients with high risk of developing these mental health related issues, healthcare provider may be better able to ensure the provision of appropriate rehabilitation to this population.

Citing Articles

Comparison of Depression, Stress, Anxiety, Cognitive Status, and Quality of Life Before and After Renal Transplantation.

Mukherjee S, Chaudhury S Cureus. 2024; 16(10):e71983.

PMID: 39569239 PMC: 11578609. DOI: 10.7759/cureus.71983.


Development and Validation of a Nomogram Model for Accurately Predicting Depression in Maintenance Hemodialysis Patients: A Multicenter Cross-Sectional Study in China.

Zhou X, Zhu F Risk Manag Healthc Policy. 2024; 17:2111-2123.

PMID: 39246589 PMC: 11380485. DOI: 10.2147/RMHP.S456499.


Prevalence and determinant factors of depression and anxiety in people with chronic kidney disease: a Moroccan cross-sectional study.

Alaoui A, Omari M, Quarmich N, Kouiri O, Chouhani B, Berraho M Pan Afr Med J. 2024; 48:15.

PMID: 39184851 PMC: 11343502. DOI: 10.11604/pamj.2024.48.15.42881.


Psychometric and structural properties of the traditional Chinese version of the sleep condition indicator for patients undergoing hemodialysis.

Chang Y, Lee H, Liao Y, Guu T, Guo S, Hasan F Sleep Breath. 2024; 28(5):2197-2204.

PMID: 38935268 DOI: 10.1007/s11325-024-03041-0.


Shared genetic effect of kidney function on bipolar and major depressive disorders: a large-scale genome-wide cross-trait analysis.

Yu S, Lin Y, Yang Y, Jin X, Liao B, Lu D Hum Genomics. 2024; 18(1):60.

PMID: 38858783 PMC: 11165782. DOI: 10.1186/s40246-024-00627-3.